drugset / Trial / NCT01243567

Safety and Efficacy of Bimatoprost/Timolol Fixed Combination Versus Latanoprost in Patients With Open-Angle Glaucoma Who Have Never Been Treated

NCT01243567

Phase 4 Completed 81 enrolled Allergan
RandomizedParallel-groupSingle-blindTreatment

Summary

This study will evaluate the safety and efficacy of bimatoprost/timolol fixed combination (GANfort®) versus latanoprost (Xalatan®) in patients with open-angle glaucoma who have never been previously treated and are at high risk for progression.

Timeline

Start
2010-06-01
Primary completion
2012-02-14
Completion
2012-02-14

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bimatoprost Other / unclassified 0.03 % Other
Comparator Latanoprost Small molecule 0.005 % Other
Comparator Timolol Other / unclassified 0.5 % Other

Indications